Cite
HARVARD Citation
Plesner, T. et al. (2021). Health‐related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial. British journal of haematology. pp. 132-139. [Online].